Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.668 EUR | 0.00% |
|
+1.21% | -24.94% |
18/06 | Traders on 'buy' side; Leonardo takes top spot | AN |
13/06 | Milan continues to fall; Hera and ERG do well | AN |
Valuation
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capitalization 1 | 17.33 | 19.43 | 7.388 | 9.766 | 7.695 | 6.17 |
Enterprise Value (EV) 1 | 28.69 | 32.05 | 17.17 | 18.46 | 11.09 | 14.44 |
P/E ratio | -13.2 x | -4.72 x | -1.29 x | -3.05 x | 1.75 x | -4.71 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | 0.29 x | 0.42 x | 0.34 x | 0.4 x | 0.31 x | 0.21 x |
EV / Revenue | 0.49 x | 0.69 x | 0.79 x | 0.76 x | 0.45 x | 0.5 x |
EV / EBITDA | 100 x | -9.7 x | -3.42 x | -7.68 x | -2.4 x | -8.2 x |
EV / FCF | -5.88 x | -6.43 x | -4.59 x | 8.59 x | -2.18 x | -4.23 x |
FCF Yield | -17% | -15.5% | -21.8% | 11.6% | -45.8% | -23.6% |
Price to Book | 1.68 x | 3.11 x | -63.2 x | -4.19 x | 1.75 x | 1.92 x |
Nbr of stocks (in thousands) | 5,113 | 5,113 | 5,113 | 5,113 | 5,113 | 6,932 |
Reference price 2 | 3.390 | 3.800 | 1.445 | 1.910 | 1.505 | 0.8900 |
Announcement Date | 19/04/19 | 31/03/20 | 17/06/22 | 17/10/22 | 08/04/23 | 07/06/24 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 58.86 | 46.76 | 21.65 | 24.18 | 24.66 | 28.74 |
EBITDA 1 | 0.287 | -3.304 | -5.015 | -2.405 | -4.622 | -1.762 |
EBIT 1 | -0.694 | -3.832 | -5.46 | -2.745 | -4.624 | -2.036 |
Operating Margin | -1.18% | -8.2% | -25.21% | -11.35% | -18.75% | -7.09% |
Earnings before Tax (EBT) 1 | -1.248 | -4.198 | -6.044 | -3.258 | 5.547 | -1.225 |
Net income 1 | -1.314 | -4.118 | -5.708 | -3.202 | 5.967 | -1.307 |
Net margin | -2.23% | -8.81% | -26.36% | -13.24% | 24.2% | -4.55% |
EPS 2 | -0.2570 | -0.8054 | -1.116 | -0.6262 | 0.8608 | -0.1890 |
Free Cash Flow 1 | -4.876 | -4.983 | -3.737 | 2.149 | -5.078 | -3.414 |
FCF margin | -8.28% | -10.66% | -17.26% | 8.89% | -20.59% | -11.88% |
FCF Conversion (EBITDA) | - | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 19/04/19 | 31/03/20 | 17/06/22 | 17/10/22 | 08/04/23 | 07/06/24 |
Balance Sheet Analysis
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | 11.4 | 12.6 | 9.78 | 8.7 | 3.39 | 8.27 |
Net Cash position 1 | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | 39.58 x | -3.82 x | -1.95 x | -3.615 x | -0.7343 x | -4.696 x |
Free Cash Flow 1 | -4.88 | -4.98 | -3.74 | 2.15 | -5.08 | -3.41 |
ROE (net income / shareholders' equity) | -12.3% | -46.4% | -147% | 691% | 249% | -30.1% |
ROA (Net income/ Total Assets) | -0.73% | -4.45% | -7.89% | -4.34% | -7.76% | -3.85% |
Assets 1 | 180.6 | 92.61 | 72.36 | 73.72 | -76.89 | 33.99 |
Book Value Per Share 2 | 2.020 | 1.220 | -0.0200 | -0.4600 | 0.8600 | 0.4600 |
Cash Flow per Share 2 | 1.280 | 0.8000 | 0.9500 | 1.030 | 0.7000 | 0.4600 |
Capex 1 | 0.95 | 0.33 | 0.18 | 0.03 | 0.09 | 0.17 |
Capex / Sales | 1.61% | 0.71% | 0.85% | 0.12% | 0.38% | 0.6% |
Announcement Date | 19/04/19 | 31/03/20 | 17/06/22 | 17/10/22 | 08/04/23 | 07/06/24 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
-24.94% | 2.22Cr | |
-13.00% | 1.32TCr | |
+2.22% | 524.99Cr | |
-3.87% | 477.53Cr | |
+15.94% | 462.93Cr | |
+64.32% | 413.32Cr | |
+6.26% | 400.86Cr | |
+4.50% | 356.84Cr | |
-31.99% | 372.57Cr | |
+2.17% | 336.29Cr |
- Stock Market
- Equities
- FDA Stock
- Financials Fidia S.p.A.